At a glance
- Originator Cortech
- Class Analgesics; Anti-inflammatories; Antiasthmatics
- Mechanism of Action Bradykinin B2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 28 Jun 2001 CP 0597 is available for licensing
- 27 Aug 1997 Preclinical development for Stroke in USA (Unknown route)